As expected, we observed a dose-dependent increase in proteins from M1 (BBB/Plasma) and other blood-associated modules, such as M10 (Peroxidase/Hb), with increasing plasma concentrations in AD CSF. This evidence concerns the gene GSTM1 and Alzheimer disease.